ReNeuron Group PLC (AIM:RENE, OTC:RNUGF) said that Iain Ross, executive chairman, had purchased 150,000 ordinary shares
Following this transaction, Ross's total holding in the exosomes technologies specialist will be 550,000 shares or 0.96% of the total in issue.